График акции VBI Vaccines Inc.
Расширенный график
Простой график
О компании
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines to treat immuno-oncology and infectious disease. It offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. The company also develops VBI-2601, an immunotherapeutic candidate for the treatment of chronic HBV infection; VBI-1901, a glioblastoma vaccine immunotherapeutic candidate, which is in Phase I/IIa clinical study to treat solid tumors; VBI-1501, a prophylactic cytomegalovirus vaccine candidate that has completed Phase I clinical trial; and VBI-2501 that is in preclinical trial to treat Zika virus. Подробнее| Выручка | 0.0022 |
|---|---|
| EBITDA | -0.0461 |
| P/S | 2.47 |
| P/BV | 0.0623 |
| EV/EBITDA | 0.5178 |
| Цена ао | 0.58 |
| ISIN | CA91822J1030 |
| Число акций ао | 0.01557 млрд |
| Сайт | https://www.vbivaccines.com |
| Див.доход ао | 0 |
| Дивиденд ао | 0.25 |
| Валюта | usd |
| IPO date | 1995-08-18 |
| Sector | Health Care |
| Industry | Biotechnology |
| Валюта отчета | usd |
| Изменение цены за день: | 0% (0.0282) |
|---|---|
| Изменение цены за неделю: | 0% (0.0282) |
| Изменение цены за месяц: | 0% (0.0282) |
| Изменение цены за 3 месяца: | -96.15% (0.7329) |
| Изменение цены за полгода: | -95.37% (0.609) |
| Изменение цены за год: | -94.87% (0.55) |
| Изменение цены за 3 года: | -99.05% (2.96) |
| Изменение цены за 5 лет: | -95.46% (0.6217) |
| Изменение цены с начала года: | -95.91% (0.69) |
|
|
Недооценка
|
Эффективность
|
|||||||||||||||||||||||||||||||||||||
Дивиденды
|
Долг
|
Импульс роста
|
|||||||||||||||||||||||||||||||||||||
| Институционалы | Объем | Доля, % |
|---|---|---|
| Perceptive Advisors LLC | 1381355 | 5.83 |
| Alyeska Investment Group, L.P. | 696736 | 2.94 |
| Geode Capital Management, LLC | 138729 | 0.59 |
| Blackrock Inc. | 111960 | 0.47 |
| Cambridge Investment Research Advisors Inc. | 93556 | 0.39 |
| Millennium Management LLC | 71422 | 0.3 |
| Vanguard Group Inc | 64522 | 0.27 |
| General American Investors Company Inc | 62583 | 0.26 |
| Morgan Stanley | 34973 | 0.15 |
| Northern Trust Corporation | 32992 | 0.14 |
| Руководитель | Должность | Оплата | Год рождения |
|---|---|---|---|
| Mr. Jeffery R. Baxter FCMA | President, CEO & Director | 908.06k | 1961 (63 года) |
| Dr. Francisco Diaz-Mitoma FRCPC, M.D., Ph.D. | Chief Medical Officer | 544.52k | 1955 (69 лет) |
| Ms. Nell Beattie | CFO, Head of Corporate Development & Director | N/A | 1988 (36 лет) |
| Ms. Athena Kartsaklis | Senior VP of Finance, Chief Compliance Officer & Principal Financial Officer | N/A | 1965 (59 лет) |
| Mr. Avi Mazaltov | Global Head of Manufacturing & GM of SciVac | N/A | 1962 (62 года) |
| Mr. Misha Nossov | Senior VP of Global Commercial Supply Strategy & Head of Europe | N/A | |
| Mr. John Robert Dillman | Chief Commercial Officer | N/A | 1968 (56 лет) |
| Dr. David Evander Anderson Ph.D. | Chief Scientific Officer | 1970 (54 года) | |
| Ms. Nicole Anderson | Director of Corporate Communications & Investor Relations | ||
| Mr. T. Adam Buckley B.Sc., MBA | Senior Vice President of Business Development | 1976 (48 лет) |
Адрес: United States, Cambridge. MA, 160 Second Street - открыть в Google картах, открыть Яндекс картах
Сайт: https://www.vbivaccines.com
Сайт: https://www.vbivaccines.com
